BMC Gastroenterol

1. EL-DIN ZS, Abdelsameea E, Awad SM, Arab DE, et al
   Prevalence, microbiological profile, and outcomes of spontaneous bacterial and fungal peritonitis in Egyptian patients with liver cirrhosis.
   BMC Gastroenterol. 2026;26:326.
   

   >> Share

   
   

   
   Dig Dis Sci

2. CHOI G, Jesudian AB, Saab S
   Optimizing Care in Primary Biliary Cholangitis: Current Treatments and the Second-Line Decision.
   Dig Dis Sci. 2025 Nov 21. doi: 10.1007/s10620-025-09537.
   

   >> Share

   
   
3. LIANG Y, Hu N, Xia X, Li F, et al
   Exploring Transcriptomic and MRI-Derived Parameters Correlations in NAFLD Fibrosis: Insights from a Rat Model.
   Dig Dis Sci. 2026;71:1972-1986.
   

   >> Share

   
   
4. XUE Q, Peng F, Guo C, Zhou Y, et al
   S100A6 Regulated by PATZ1 Promotes Liver Fibrosis by Activating Hepatic Stellate Cells.
   Dig Dis Sci. 2025 Nov 13. doi: 10.1007/s10620-025-09533.
   

   >> Share

   
   

   
   Gastroenterology

5. KIM GA, Jang H, Kim MY, Park JH, et al
   Multicenter Prospective Cohort Study on Clinical Outcomes and Fibrosis Patterns in Biopsy-Proven Steatotic Liver Disease Subtypes.
   Gastroenterology. 2026;170:1571-1583.
   

   >> Share

   
   

   
   J Gastroenterol

6. AKUTA N, Kogiso T, Ikejima K, Otsuka M, et al
   Evidence-based clinical practice guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD) 2026.
   J Gastroenterol. 2026;61:693-710.
   

   >> Share

   
   
7. KAWATA K, Takahashi H, Arai T, Seko Y, et al
   Impact of cardiometabolic criteria on the pathogenesis of MASLD and diagnostic performance of non-invasive tests.
   J Gastroenterol. 2026;61:783-795.
   

   >> Share

   
   

   
   PLoS One

8. POH WY, Azzeri A, Zain SM, Mohamed R, et al
   Cost-effectiveness of various referral pathways to identify advanced fibrosis among type 2 diabetes mellitus patients with metabolic dysfunction-associated steatotic liver disease in primary care setting in Malaysia.
   PLoS One. 2026;21:e0350263.
   

   >> Share

   
   

   
   Proc Natl Acad Sci U S A

9. HUANG X, Hao J, Wang S, Deng B, et al
   mRNA-laden LNP-enabled in situ CAR-macrophage alleviates liver fibrosis via inhibiting activated HSCs and modulating the immune microenvironment.
   Proc Natl Acad Sci U S A. 2026;123:e2534673123.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share